Form 4: RB Global CEO Exercises Options, Sells Shares Under Pre-Arranged Plan

RB Global CEO James F. Kessler exercised stock options and simultaneously sold a portion of common shares for a significant gain, as disclosed in a recent SEC Form 4 filing.

Summary

• CEO James F. Kessler exercised 45,658 employee stock options at a price of $54.83 per share on July 14, 2025.
• Concurrently, Kessler sold 45,658 common shares at a price of $110 per share on July 14, 2025.
• The transactions were executed under a Rule 10b5-1 pre-arranged trading plan.
• Following these transactions, Kessler's direct beneficial ownership of common shares is 107,569, in addition to 1,823 shares held indirectly through an Employee Stock Purchase Plan.
• The exercised options were granted on February 25, 2021, and vested in three equal annual installments starting February 25, 2022.

Sentiment

Score: 7

Explanation: The transaction reflects an executive realizing value from vested compensation, which is a normal part of executive compensation. The sale under a 10b5-1 plan indicates a pre-planned transaction rather than a reaction to new information. While it reduces direct ownership, it's a common and expected event.

Positives

• CEO realized a significant profit from exercising options and selling shares, with a sale price of $110 compared to an exercise price of $54.83.
• The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-planned and transparent sale.

Negatives

• A reduction in direct beneficial ownership by the CEO, from 153,227 shares to 107,569 shares, could be perceived as a decrease in insider alignment, although the sale was pre-planned.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May observe a reduction in direct insider ownership, though the pre-planned nature mitigates concerns.
• Employees: The transaction highlights the value of executive compensation plans, including stock options.

Key Dates

Recommendation

Keywords

RB Global, RBA, James F. Kessler, CEO, stock options, insider trading, Form 4, SEC filing, share sale, Rule 10b5-1